These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31266288)

  • 41. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
    Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
    Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Qiu B; Li J; Wang B; Wang Z; Liang Y; Cai P; Chen Z; Liu M; Fu J; Yang H; Liu H
    J Cancer; 2017; 8(2):249-257. PubMed ID: 28243329
    [No Abstract]   [Full Text] [Related]  

  • 43. Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Weiss JM; Grilley-Olson JE; Deal AM; Zevallos JP; Chera BS; Paul J; Knowles MF; Usenko D; Weissler MC; Patel S; Hayes DN; Hackman T
    Cancer; 2018 Jul; 124(14):2986-2992. PubMed ID: 29741773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue.
    Goineau A; Piot B; Malard O; Ferron C; Lisbona A; Cassagnau E; Delamazure AS; Campion L; Bardet E
    Brachytherapy; 2015; 14(1):71-6. PubMed ID: 25454575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Concurrent chemoradiotherapy for resectable locoregionally advanced squamous cell carcinoma of the head and neck-analysis of factors associated with toxicity and efficacy].
    Kubota A; Furukawa M; Fujita Y; Yagi H
    Nihon Jibiinkoka Gakkai Kaiho; 2010 Mar; 113(3):101-9. PubMed ID: 20387597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
    Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
    Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term regional control and survival in patients with "low-risk," early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness.
    Ganly I; Goldstein D; Carlson DL; Patel SG; O'Sullivan B; Lee N; Gullane P; Shah JP
    Cancer; 2013 Mar; 119(6):1168-76. PubMed ID: 23184439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
    Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.
    Goto M; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hyodo I; Kodaira T; Ogawa T; Fujimoto Y; Terada A; Kato H; Hasegawa Y
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e141-8. PubMed ID: 23909955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined-modality treatment for advanced oral tongue squamous cell carcinoma.
    Fan KH; Lin CY; Kang CJ; Huang SF; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):453-61. PubMed ID: 17236967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer.
    Zahoor H; Elson P; Stephenson A; Haber GP; Kaouk J; Fergany A; Lee B; Koshkin V; Ornstein M; Gilligan T; Garcia JA; Rini B; Grivas P
    Clin Genitourin Cancer; 2018 Apr; 16(2):e437-e442. PubMed ID: 29154041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma.
    Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.
    Suzuki-Shibata S; Yamamoto Y; Yoshida T; Mizoguchi N; Nonaka T; Kubota A; Narimatsu H; Miyagi Y; Kobayashi T; Kaneta T; Inoue T
    Jpn J Radiol; 2017 Dec; 35(12):740-747. PubMed ID: 29039110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
    Ling W; Mijiti A; Moming A
    J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
    Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
    Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool.
    Alabi RO; Elmusrati M; Sawazaki-Calone I; Kowalski LP; Haglund C; Coletta RD; Mäkitie AA; Salo T; Leivo I; Almangush A
    Virchows Arch; 2019 Oct; 475(4):489-497. PubMed ID: 31422502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age.
    Ansarin M; De Berardinis R; Corso F; Giugliano G; Bruschini R; De Benedetto L; Zorzi S; Maffini F; Sovardi F; Pigni C; Scaglione D; Alterio D; Cossu Rocca M; Chiocca S; Gandini S; Tagliabue M
    Front Oncol; 2021; 11():616653. PubMed ID: 33912446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.